Cryopyrin associated periodic syndrome
Information
- Disease name
- Cryopyrin associated periodic syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01105507 | Completed | Phase 3 | The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada | August 2010 | May 12, 2012 |
| NCT04086602 | Completed | Phase 1 | Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 | September 13, 2019 | February 4, 2020 |
| NCT04856540 | Completed | Adult Outcomes of Children With CAPS | September 16, 2021 | February 25, 2022 | |
| NCT05186051 | Completed | Phase 2 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) | June 1, 2022 | July 2, 2022 |
| NCT05812781 | Completed | Phase 2 | A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome | March 18, 2023 | March 6, 2024 |
| NCT05292768 | Not yet recruiting | Are Mast Cells Involved in Autoinflammatory Diseases | March 2022 | October 2026 |